Resveratrol Enhances Cytotoxic Effects of Cisplatin by Inducing Cell Cycle Arrest and Apoptosis in Ovarian Adenocarcinoma SKOV-3 Cells through Activating the p38 MAPK and Suppressing AKT

被引:17
作者
Hankittichai, Phateep [1 ]
Thaklaewphan, Phatarawat [1 ]
Wikan, Nitwara [1 ]
Ruttanapattanakul, Jirapak [1 ]
Potikanond, Saranyapin [1 ,2 ]
Smith, Duncan R. [3 ]
Nimlamool, Wutigri [1 ,2 ]
机构
[1] Chiang Mai Univ, Fac Med, Dept Pharmacol, Chiang Mai 50200, Thailand
[2] Chiang Mai Univ, Fac Pharm, Res Ctr Pharmaceut Nanotechnol, Chiang Mai 50200, Thailand
[3] Mahidol Univ, Inst Mol Biosci, Nakhon Pathom 73170, Thailand
关键词
resveratrol; ovarian clear cancer; ovarian adenocarcinoma; SKOV-3; cells; p38 MAPK activation; PI3K/AKT; SIGNALING PATHWAYS; CANCER CELLS; RESISTANCE; OVEREXPRESSION; EPIDEMIOLOGY; PATHOGENESIS; KINASE; LUNG; P53;
D O I
10.3390/ph16050755
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In the current study, we identified a mechanism of resveratrol (RES) underlying its anti-cancer properties against human ovarian adenocarcinoma SKOV-3 cells. We investigated its anti-proliferative and apoptosis-inducing effects in combination with cisplatin, using cell viability assay, flow cytometry, immunofluorescence study and Western blot analysis. We discovered that RES suppressed cancer cell proliferation and stimulated apoptosis, especially when combined with cisplatin. This compound also inhibited SKOV-3 cell survival, which may partly be due to its potential to inhibit protein kinase B (AKT) phosphorylation and induce the S-phase cell cycle arrest. RES in combination with cisplatin strongly induced cancer cell apoptosis through activating the caspase-dependent cascade, which was associated with its ability to stimulate nuclear phosphorylation of p38 mitogen-activated protein kinase (MAPK), well recognized to be involved in transducing environmental stress signals. RES-induced p38 phosphorylation was very specific, and the activation status of extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) was not mainly affected. Taken together, our study provides accumulated evidence that RES represses proliferation and promotes apoptosis in SKOV-3 ovarian cancer cells through activating the p38 MAPK pathway. It is interesting that this active compound may be used as an effective agent to sensitize ovarian cancer to apoptosis induced by standard chemotherapies.
引用
收藏
页数:18
相关论文
共 60 条
[41]   Hypoxia enhances LPA-induced HIF-1α and VEGF expression:: Their inhibition by resveratrol [J].
Park, Soon Young ;
Jeong, Kang Jin ;
Lee, Jangsoon ;
Yoon, Dae Sung ;
Choi, Wahn Soo ;
Kim, Yong Kee ;
Han, Jeung Whan ;
Kim, Yoon Mee ;
Kim, Bum Kyeong ;
Lee, Hoi Young .
CANCER LETTERS, 2007, 258 (01) :63-69
[42]   A Phase 3 Trial of Bevacizumab in Ovarian Cancer [J].
Perren, Timothy J. ;
Swart, Ann Marie ;
Pfisterer, Jacobus ;
Ledermann, Jonathan A. ;
Pujade-Lauraine, Eric ;
Kristensen, Gunnar ;
Carey, Mark S. ;
Beale, Philip ;
Cervantes, Andres ;
Kurzeder, Christian ;
du Bois, Andreas ;
Sehouli, Jalid ;
Kimmig, Rainer ;
Staehle, Anne ;
Collinson, Fiona ;
Essapen, Sharadah ;
Gourley, Charlie ;
Lortholary, Alain ;
Selle, Frederic ;
Mirza, Mansoor R. ;
Leminen, Arto ;
Plante, Marie ;
Stark, Dan ;
Qian, Wendi ;
Parmar, Mahesh K. B. ;
Oza, Amit M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (26) :2484-2496
[43]   The use of natural compounds for the targeting and chemoprevention of ovarian cancer [J].
Pistollato, Francesca ;
Calderon Iglesias, Ruben ;
Ruiz, Roberto ;
Aparicio, Silvia ;
Crespo, Jorge ;
Dzul Lopez, Luis ;
Giampieri, Francesca ;
Battino, Maurizio .
CANCER LETTERS, 2017, 411 :191-200
[44]  
Pokhriyal Ruchika, 2019, Biomark Cancer, V11, p1179299X19860815, DOI [10.1177/1179299x19860815, 10.1177/1179299X19860815]
[45]   Kaempferia parviflora Extract Exhibits Anti-cancer Activity against HeLa Cervical Cancer Cells [J].
Potikanond, Saranyapin ;
Sookkhee, Siriwoot ;
Takuathung, Mingkwan Na ;
Mungkornasawakul, Pitchaya ;
Wikan, Nitwara ;
Smith, Duncan R. ;
Nimlamool, Wutigri .
FRONTIERS IN PHARMACOLOGY, 2017, 8
[46]   Worldwide burden of gynaecological cancer: The size of the problem [J].
Sankaranarayanan, R ;
Ferlay, J .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2006, 20 (02) :207-225
[47]  
Seino M, 2015, ANTICANCER RES, V35, P85
[48]  
She QB, 2001, CANCER RES, V61, P1604
[49]   Cancer Statistics, 2015 [J].
Siegel, Rebecca L. ;
Miller, Kimberly D. ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2015, 65 (01) :5-29
[50]   Mechanisms of disseminated cancer cell dormancy: an awakening field [J].
Sosa, Maria Soledad ;
Bragado, Paloma ;
Aguirre-Ghiso, Julio A. .
NATURE REVIEWS CANCER, 2014, 14 (09) :611-622